IP Library Granted Patent US 6,905,855
Granted Patent B2
US 6,905,855 · App. 10/199,334 · Granted Jun 14, 2005

Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,905,855
App. No.
10/199,334
Granted
Jun 14, 2005
Kind
B2
Abstract

The present invention provides amino acid sequences of peptides that are encoded by genes within the human genome, the proteins of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the proteins of the present invention, and methods of identifying modulators of the proteins of the present invention.

Claims (20)

1. An isolated nucleic acid molecule consisting of a nucleotide sequence encoding a phenol sulfotransferase protein selected from the group consisting of:

(a) a nucleotide sequence that encodes a protein comprising the amino acid sequence of SEQ ID NO: 5; and

(b) a nucleotide sequence consisting of the nucleic acid sequence of SEQ ID NO: 2.

2. A nucleic acid vector comprising a nucleic acid molecule of claim 1 .

3. A host cell containing the vector of claim 2 .

4. A method for producing a polypeptide comprising culturing the host cell of claim 3 under conditions sufficient for the production of said polypeptide, and recovering the peptide from the host cell culture.

5. A method for detecting the presence of a nucleic acid molecule of claim 1 in a sample, said method comprising

contacting the sample with an oligonucleotide comprising at least 20 contiguous nucleotides that hybridizes to said nucleic acid molecule under stringent conditions, wherein the stringent conditions is hybridization in 6× sodium chloride/sodium citrate (SSC) at about 45° C., followed by one or more washes in 0.2×SSC, 0.1% SDS al 50-65° C., and

determining whether the oligonucleotide binds to said nucleic acid molecule in the sample.

6. An isolated nucleic acid molecule consisting of a nucleotide sequence that is completely complementary to a nucleotide sequence of claim 1 .

7. An isolated polynucleotide consisting of a nucleotide sequence set forth in SEQ ID NO: 2.

8. An isolated nucleic acid molecule comprising a nucleotide sequence encoding a phenol sulfotransferase protein selected from the group consisting of:

(a) a nucleotide sequence that encodes a protein comprising the amino acid sequence of SEQ ID NO: 5; and

(b) a nucleotide sequence comprising SEQ ID NO: 2.

9. A nucleic acid vector comprising a nucleic acid molecule of claim 8 .

10. A host cell containing the vector of claim 9 .

11. A vector according to claim 9 , wherein said vector is selected from the group consisting of a plasmid, virus, and bacteriophage.

12. A vector according to claim 9 , wherein said isolated nucleic acid molecule is inserted into said vector in proper orientation and correct reading frame such that the protein of SEQ ID NO: 5 may be expressed by a cell transformed with said vector.

13. A vector according to claim 12 , wherein said isolated nucleic acid molecule is operatively linked to a promoter sequence.

14. An isolated nucleic acid molecule comprising a nucleotide sequence that is completely complementary to a nucleotide sequence of claim 8 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2008
From: APPLERA CORPORATION
To: CELERA CORPORATION
Reel/Frame 021561/0124 →